Mirtazapine enantiomers in blood and cerebrospinal fluid.

作者: Pierre Baumann , Michèle Jonzier-Perey , Erik Paus , Georg Nikisch

DOI: 10.1159/000098654

关键词: StereoselectivityAntagonistChemistryMianserinCerebrospinal fluidEnantiomerMirtazapinaAntidepressantMirtazapinePharmacology

摘要: Little information exists on the concentrations of recent antidepressants and their metabolites in cerebrospinal fluid (CSF). Using a stereoselective method, we measured plasma CSF levels mirtazapine (MIR), N-demethylmirtazapine 8-OH-MIR 3 depressed patients treated with racemic MIR (45 mg/day) for 4 weeks. S-(+)-MIR is considered to be antidepressant enantiomer, but only R-(-)-MIR reached measurable CSF. For R-(-)-MIR, CSF/plasma ratio varied between 0.08 0.31. Further studies are needed test hypothesis that there possible differences transport mechanisms enantiomers at blood-CSF barrier.

参考文章(15)
Nasser Haddjeri, C. De Montigny, P. Blier, Effect of the alpha-2 adrenoceptor antagonist mirtazapine on the 5-hydroxytryptamine system in the rat brain. Journal of Pharmacology and Experimental Therapeutics. ,vol. 277, pp. 861- 871 ,(1996)
N Haddjeri, P Blier, C de Montigny, Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine. International Clinical Psychopharmacology. ,vol. 10, pp. 11- 17 ,(1995) , 10.1097/00004850-199512004-00003
Georg Nikisch, Aleksander A. Math??, Adelheid Czernik, Chin B. Eap, Patricia Jim??nez-Vasquez, Marlyse Brawand-Amey, Pierre Baumann, Stereoselective metabolism of citalopram in plasma and cerebrospinal fluid of depressive patients: relationship with 5-HIAA in CSF and clinical response. Journal of Clinical Psychopharmacology. ,vol. 24, pp. 283- 290 ,(2004) , 10.1097/01.JCP.0000125680.89843.A6
Seetal Dodd, Graham D.Burrows, Trevor R Norman, Chiral determination of mirtazapine in human blood plasma by high-performance liquid chromatography Journal of Chromatography B: Biomedical Sciences and Applications. ,vol. 748, pp. 439- 443 ,(2000) , 10.1016/S0378-4347(00)00353-4
Cees J. Timmer, J.M. Ad Sitsen, Leon P. Delbressine, Clinical pharmacokinetics of mirtazapine. Clinical Pharmacokinectics. ,vol. 38, pp. 461- 474 ,(2000) , 10.2165/00003088-200038060-00001
P. Baumann, C. Hiemke, S. Ulrich, G. Eckermann, I. Gaertner, M. Gerlach, H.-J. Kuss, G. Laux, B. Müller-Oerlinghausen, M. L. Rao, P. Riederer, G. Zernig, The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry. Pharmacopsychiatry. ,vol. 37, pp. 243- 265 ,(2004) , 10.1055/S-2004-832687
Caroline McGrath, Graham D Burrows, Trevor R Norman, Neurochemical effects of the enantiomers of mirtazapine in normal rats European Journal of Pharmacology. ,vol. 356, pp. 121- 126 ,(1998) , 10.1016/S0014-2999(98)00509-3
LPC Delbressine, MEG Moonen, FM Kaspersen, GN Wagenaars, PL Jacobs, CJ Timmer, JE Paanakker, HJM van Hal, G Voortman, Pharmacokinetics and Biotransformation of Mirtazapine in Human Volunteers Clinical Drug Investigation. ,vol. 15, pp. 45- 55 ,(1998) , 10.2165/00044011-199815010-00006
Conny Nordin, Leif Bertilsson, Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline Clinical Pharmacokinectics. ,vol. 28, pp. 26- 40 ,(1995) , 10.2165/00003088-199528010-00004